Achyut Healthcare Limited (BOM:543499)
India
· Delayed Price · Currency is INR 3.550
-0.040 (-1.11%)
At close: May 2, 2025
Achyut Healthcare Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Other Revenue | - | - | 0 | -0 | - | - | Upgrade
|
| Revenue | 67.81 | 61.37 | 26.96 | 40.49 | 2.73 | 3.34 | Upgrade
|
| Revenue Growth (YoY) | 195.96% | 127.66% | -33.43% | 1385.01% | -18.39% | -49.94% | Upgrade
|
| Cost of Revenue | 65 | 55.32 | 19.61 | 33.21 | 2.31 | 1.82 | Upgrade
|
| Gross Profit | 2.81 | 6.05 | 7.35 | 7.28 | 0.42 | 1.52 | Upgrade
|
| Selling, General & Admin | 1.7 | 1.61 | 1.2 | 0.71 | 0.01 | 0.11 | Upgrade
|
| Other Operating Expenses | 1.68 | 3.91 | 8.74 | 5.71 | 0.29 | 1.34 | Upgrade
|
| Operating Expenses | 3.53 | 5.61 | 10 | 7.67 | 0.3 | 1.45 | Upgrade
|
| Operating Income | -0.72 | 0.44 | -2.66 | -0.39 | 0.11 | 0.08 | Upgrade
|
| Interest Expense | -0.02 | -0.02 | -0.02 | - | -0 | -0 | Upgrade
|
| Interest & Investment Income | 6.92 | 6.92 | 5.78 | 1.39 | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | 0.07 | -0.02 | 0 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 2.43 | 0 | 0 | - | 0.01 | -0 | Upgrade
|
| EBT Excluding Unusual Items | 8.68 | 7.41 | 3.1 | 1.01 | 0.13 | 0.07 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | 0.12 | Upgrade
|
| Pretax Income | 8.68 | 7.41 | 3.1 | 1.01 | 0.13 | 0.19 | Upgrade
|
| Income Tax Expense | 2.03 | 1.68 | 0.78 | 0.6 | 0.02 | 0.05 | Upgrade
|
| Net Income | 6.65 | 5.73 | 2.31 | 0.4 | 0.11 | 0.14 | Upgrade
|
| Net Income to Common | 6.65 | 5.73 | 2.31 | 0.4 | 0.11 | 0.14 | Upgrade
|
| Net Income Growth | 164.24% | 147.92% | 473.70% | 279.57% | -24.16% | - | Upgrade
|
| Shares Outstanding (Basic) | 257 | 236 | 196 | 142 | 10 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 257 | 236 | 196 | 142 | 10 | 10 | Upgrade
|
| Shares Change (YoY) | 34.14% | 20.03% | 38.63% | 1319.16% | - | - | Upgrade
|
| EPS (Basic) | 0.03 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | Upgrade
|
| EPS (Diluted) | 0.03 | 0.02 | 0.01 | 0.00 | 0.01 | 0.01 | Upgrade
|
| EPS Growth | 96.99% | 106.54% | 313.95% | -73.26% | -24.16% | - | Upgrade
|
| Free Cash Flow | -106.07 | -63.7 | -37.47 | -69.89 | 0.09 | -0.23 | Upgrade
|
| Free Cash Flow Per Share | -0.41 | -0.27 | -0.19 | -0.49 | 0.01 | -0.02 | Upgrade
|
| Gross Margin | 4.15% | 9.85% | 27.25% | 17.99% | 15.29% | 45.62% | Upgrade
|
| Operating Margin | -1.06% | 0.71% | -9.85% | -0.96% | 4.15% | 2.31% | Upgrade
|
| Profit Margin | 9.81% | 9.34% | 8.58% | 1.00% | 3.89% | 4.19% | Upgrade
|
| Free Cash Flow Margin | -156.43% | -103.79% | -139.00% | -172.59% | 3.34% | -6.76% | Upgrade
|
| EBITDA | -0.57 | 0.52 | -2.59 | -0.33 | - | - | Upgrade
|
| EBITDA Margin | -0.84% | 0.85% | -9.62% | -0.83% | - | - | Upgrade
|
| D&A For EBITDA | 0.15 | 0.09 | 0.06 | 0.05 | - | - | Upgrade
|
| EBIT | -0.72 | 0.44 | -2.66 | -0.39 | 0.11 | 0.08 | Upgrade
|
| EBIT Margin | -1.06% | 0.71% | -9.85% | -0.96% | 4.15% | 2.31% | Upgrade
|
| Effective Tax Rate | 23.40% | 22.67% | 25.32% | 59.90% | 15.63% | 25.93% | Upgrade
|
| Revenue as Reported | 77.5 | 68.63 | 32.87 | 41.94 | 2.74 | 3.46 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.